[HTML][HTML] Old drug, new delivery strategy: MMAE repackaged
H Lahnif, T Grus, EA Salvanou, E Deligianni… - International Journal of …, 2023 - mdpi.com
Targeting therapy is a concept that has gained significant importance in recent years,
especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate …
especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate …
Old Drug, New Delivery Strategy: MMAE Repackaged
H Lahnif, T Grus, E Salvanou, E Deligianni… - … Journal of Molecular …, 2023 - europepmc.org
Targeting therapy is a concept that has gained significant importance in recent years,
especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate …
especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate …
Old Drug, New Delivery Strategy: MMAE Repackaged
H Lahnif, T Grus, EA Salvanou, E Deligianni… - 2023 - helios-eie.ekt.gr
Targeting therapy is a concept that has gained significant importance in recent years,
especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate …
especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate …
Old Drug, New Delivery Strategy: MMAE Repackaged
H Lahnif, T Grus, EA Salvanou… - International …, 2023 - pubmed.ncbi.nlm.nih.gov
Targeting therapy is a concept that has gained significant importance in recent years,
especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate …
especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate …
[HTML][HTML] Old Drug, New Delivery Strategy: MMAE Repackaged
H Lahnif, T Grus, EA Salvanou… - … Journal of Molecular …, 2023 - ncbi.nlm.nih.gov
Targeting therapy is a concept that has gained significant importance in recent years,
especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate …
especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate …
Old Drug, New Delivery Strategy: MMAE Repackaged.
H Lahnif, T Grus, EA Salvanou… - International …, 2023 - search.ebscohost.com
Targeting therapy is a concept that has gained significant importance in recent years,
especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate …
especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate …
[PDF][PDF] Old drug, new delivery strategy: MMAE repackaged
H Lahnif - Development of novel small-molecule drug … - openscience.ub.uni-mainz.de
Background: Targeted therapy is a concept that has gained significant importance in the last
years, especially in oncology. The severe dose-limiting side effects of chemotherapy …
years, especially in oncology. The severe dose-limiting side effects of chemotherapy …
Old Drug, New Delivery Strategy: MMAE Repackaged
H Lahnif, T Grus, EA Salvanou… - International …, 2023 - search.proquest.com
Targeting therapy is a concept that has gained significant importance in recent years,
especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate …
especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate …
[PDF][PDF] Old drug, new delivery strategy: MMAE repackaged
H Lahnif - Development of novel small-molecule drug conjugates … - d-nb.info
Background: Targeted therapy is a concept that has gained significant importance in the last
years, especially in oncology. The severe dose-limiting side effects of chemotherapy …
years, especially in oncology. The severe dose-limiting side effects of chemotherapy …
Old Drug, New Delivery Strategy: MMAE Repackaged.
H Lahnif, T Grus, EA Salvanou, E Deligianni… - … Journal of Molecular …, 2023 - europepmc.org
Targeting therapy is a concept that has gained significant importance in recent years,
especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate …
especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate …